Paper37830006
The use of N-of-1 trials to generate real-world evidence for optimal treatment of individuals and populations.
Selker HP and 4 others. J Clin Transl Sci, 2023. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. The use of N-of-1 trials to generate real-world evidence for optimal treatment of individuals and populations. Papers, record 37830006. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37830006
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The use of N-of-1 trials to generate real-world evidence for optimal treatment of individuals and populations.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27376097 | Appreciating the Nuance of Daily Symptom Variation to Individualize Patient Care. | EGEMS (Wash DC) | 2016 | https://conductscience.org/library/papers/27376097 | PubMed |
| 2 | 34642487 | Individualized therapy trials: navigating patient care, research goals and ethics. | Nat Med | 2021 | https://conductscience.org/library/papers/34642487 | PubMed |
| 3 | 36863730 | Replacing RCTs with real world data for regulatory decision making: a self-fulfilling prophecy? | BMJ | 2023 | https://conductscience.org/library/papers/36863730 | PubMed |
| 4 | 31698713 | N-of-1 Trials as a Decision Support Tool in Clinical Practice: A Protocol for a Systematic Literature Review and Narrative Synthesis. | Healthcare (Basel) | 2019 | https://conductscience.org/library/papers/31698713 | PubMed |
| 5 | 38009129 | Conduct and Implementation of Personalized Trials in Research and Practice. | Harv Data Sci Rev | 2022 | https://conductscience.org/library/papers/38009129 | PubMed |
| 6 | 31597037 | Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease. | N Engl J Med | 2019 | https://conductscience.org/library/papers/31597037 | PubMed |
| 7 | 9179098 | Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment. | J Clin Epidemiol | 1997 | https://conductscience.org/library/papers/9179098 | PubMed |
| 8 | 8133588 | Randomized clinical trials in single patients during a 2-year period. | JAMA | 1993 | https://conductscience.org/library/papers/8133588 | PubMed |
| 9 | 31754660 | Making the switch: From case studies to N-of-1 trials. | Epilepsy Behav Rep | 2019 | https://conductscience.org/library/papers/31754660 | PubMed |
| 10 | 30193253 | Effect of Mobile Device-Supported Single-Patient Multi-crossover Trials on Treatment of Chronic Musculoskeletal Pain: A Randomized Clinical Trial. | JAMA Intern Med | 2018 | https://conductscience.org/library/papers/30193253 | PubMed |
| 11 | 28902570 | Tragedy, Perseverance, and Chance - The Story of CAR-T Therapy. | N Engl J Med | 2017 | https://conductscience.org/library/papers/28902570 | PubMed |
| 12 | 36605403 | An approach to data collection in compassionate use/managed access. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36605403 | PubMed |
| 13 | 37706004 | Applying real-world data from expanded-access ("compassionate use") patients to drug development. | J Clin Transl Sci | 2023 | https://conductscience.org/library/papers/37706004 | PubMed |
| 14 | 31570318 | The future of cystic fibrosis care: a global perspective. | Lancet Respir Med | 2020 | https://conductscience.org/library/papers/31570318 | PubMed |
| 15 | 20863658 | Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations. | J Clin Epidemiol | 2010 | https://conductscience.org/library/papers/20863658 | PubMed |
| 16 | 34551122 | A Useful and Sustainable Role for N-of-1 Trials in the Healthcare Ecosystem. | Clin Pharmacol Ther | 2022 | https://conductscience.org/library/papers/34551122 | PubMed |
| 17 | 9925061 | Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice. | Chest | 1999 | https://conductscience.org/library/papers/9925061 | PubMed |
| 18 | 34797920 | Real-World Evidence in EU Medicines Regulation: Enabling Use and Establishing Value. | Clin Pharmacol Ther | 2022 | https://conductscience.org/library/papers/34797920 | PubMed |
| 19 | 17014022 | Lessons learned combining N-of-1 trials to assess fibromyalgia therapies. | J Rheumatol | 2006 | https://conductscience.org/library/papers/17014022 | PubMed |
| 20 | 27107878 | N-of-1 trials can be aggregated to generate group mean treatment effects: a systematic review and meta-analysis. | J Clin Epidemiol | 2016 | https://conductscience.org/library/papers/27107878 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42729723 | Establishing Core Outcome Sets to Advance Evidence Synthesis in Behavior Analysis. | Perspect Behav Sci | 2026 | https://conductscience.org/library/papers/42729723 | PubMed |
| 42596576 | Strengthening Rural Health With N-of-1 Trials and Single-Case Experimental Designs. | Aust J Rural Health | 2026 | https://conductscience.org/library/papers/42596576 | PubMed |
| 41872601 | Five tenets for advancing evidence-based precision medicine. | Nat Med | 2026 | https://conductscience.org/library/papers/41872601 | PubMed |
| 41590516 | Randomized Personalized Trial for Stress Management Compared to Standard of Care. | J Pers Med | 2026 | https://conductscience.org/library/papers/41590516 | PubMed |
| 41459511 | Conceptual quantitative systems pharmacology framework for supporting clinical trial design in organ-specific autoimmune and rare diseases. | Front Immunol | 2025 | https://conductscience.org/library/papers/41459511 | PubMed |
| 41355573 | N-of-1 trials in clinical research: Methodological foundations, statistical approaches and implementation challenges. | Br J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/41355573 | PubMed |
| 41122189 | The N-of-1 Trials and where to use them in Rheumatology. | Mediterr J Rheumatol | 2025 | https://conductscience.org/library/papers/41122189 | PubMed |
| 41113758 | Drug Development for Pulmonary Arterial Hypertension: Unleashing the Potential of Single-Patient Studies Using Continuous Monitoring. | Pulm Circ | 2025 | https://conductscience.org/library/papers/41113758 | PubMed |
| 40447582 | From precision interventions to precision health. | Nat Commun | 2025 | https://conductscience.org/library/papers/40447582 | PubMed |
| 40176845 | Beyond p-values: a cross-sectional umbrella review of chemotherapy-induced peripheral neuropathy treatments. | Front Pain Res (Lausanne) | 2025 | https://conductscience.org/library/papers/40176845 | PubMed |
| 39507541 | Molecular and modular intricacies of precision oncology. | Front Immunol | 2024 | https://conductscience.org/library/papers/39507541 | PubMed |
| 38784107 | Advancing regulatory science through real-world data and real-world evidence. | J Clin Transl Sci | 2024 | https://conductscience.org/library/papers/38784107 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37830006
GET https://conductscience.org/api/papers/v1/37830006/authors